pfspz
Vaccineexperimental
Clinical trial activity
31 trials · 34 clinical orgs · 0 marketing orgs
Phase 1
26
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Sep 14, 2011 (NCT01441167)
Timeline
Indications
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pfspz
- pfspz (7g8)
- pfspz-ga1 vaccine
- pfspz vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06862453 | Phase 1 | Jul 30, 2025 | Leiden University, Sanaria Inc., Stanford University, University of California, Los Angeles |
| NCT06735209 | Phase 1 | Feb 1, 2025 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT06652737 | Phase 1 | Jan 31, 2025 | Groupe de Recherche Action en Santé (GRAS), Burkina Faso, Sanaria Inc., University of Maryland, University of Washington |
| NCT05652504 | Phase 1 | Dec 29, 2022 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT05604521 | Phase 1 | Oct 25, 2022 | Sanaria Inc., University of Maryland |
| NCT04940130 | Phase 2 | Apr 30, 2022 | Malaria Research and Training Center, Bamako, Mali, National Institute of Allergy and Infectious Diseases (NIAID), Sanaria Inc., University of the Sciences, Techniques and Technologies of Bamako |
| NCT04966871 | Phase 1 | Sep 27, 2021 | Sanaria Inc., University of Washington |
| NCT03989102 | Phase 2 | Jul 5, 2019 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT03503058 | Phase 2 | Mar 31, 2019 | Department of Defense, Eijkman Institute for Molecular Biology, Jakarta, Indonesia, Sanaria Inc., University of Indonesia |
| NCT03510481 | Phase 1 | Oct 5, 2018 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT03590340 | Phase 1 | Jul 30, 2018 | Atlantic Methanol Production Company, Equatorial Guinea Liquefied Natural Gas, Government of Equatorial Guinea, Ifakara Health Institute, Marathon Oil Corporation, Noble Organisation, Sanaria Inc., University of Basel |
| NCT03521973 | Phase 2 | Jun 14, 2018 | Centre de Recherches Médicales de Lambaréné, Sanaria Inc. |
| NCT03420053 | Phase 1 | Feb 7, 2018 | Ifakara Health Institute, Medical Care Development, Inc., Sanaria Inc., University of Basel |
| NCT03163121 | Phase 1 | May 1, 2017 | Leiden University, Radboud University, Sanaria Inc. |
| NCT02859350 | Phase 1 | Nov 1, 2016 | Government of Equatorial Guinea, Ifakara Health Institute, La Paz Medical Center, Malabo, Equatorial Guinea, Marathon Oil Corporation, Noble Organisation, Sanaria Inc., University of Basel |
| NCT02773979 | Phase 1 | Sep 12, 2016 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02704533 | Phase 1 | Sep 1, 2016 | German Center for Infection Research, German Federal Ministry of Education and Research, Sanaria Inc., University of Tuebingen |
| NCT02780154 | Phase 1 | Aug 25, 2016 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02687373 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2016 | Centers for Disease Control and Prevention (CDC), Kenya Medical Research Institute, National Institutes of Health (NIH), Sanaria Inc., University of Maryland |
| NCT02663700 | Phase 1 | Apr 7, 2016 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 20 of 31 trials
Page 1 / 2
Organizations
Research & Development (34)
34 organizations
Page 1 / 2